A citation-based method for searching scientific literature

Bertrand Pain, Camille Baquerre, Muriel Coulpier. Vet Res 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis.
Julian R F Walters, Ali M Tasleem, Omer S Omer, W Gordon Brydon, Tracy Dew, Carel W le Roux. Clin Gastroenterol Hepatol 2009
221
100

Evaluating the Role of Solubility in Oral Absorption of Poorly Water-Soluble Drugs Using Physiologically-Based Pharmacokinetic Modeling.
Christina Fink, Dajun Sun, Knut Wagner, Melanie Schneider, Holger Bauer, Hugues Dolgos, Karsten Mäder, Sheila-Annie Peters. Clin Pharmacol Ther 2020
10
100

Dermatologic side effects associated with gefitinib therapy: clinical experience and management.
Roy S Herbst, Patricia M LoRusso, Michele Purdom, Deborah Ward. Clin Lung Cancer 2003
85
100

EGFR inhibitor-driven endoplasmic reticulum stress-mediated injury on intestinal epithelial cells.
Shaocheng Hong, Yanhong Gu, Zhenzhen Gao, Lele Guo, Wenjie Guo, Xudong Wu, Yan Shen, Yang Sun, Xuefeng Wu, Qiang Xu. Life Sci 2014
13
100

HCT116 cells deficient in p21(Waf1) are hypersensitive to tyrosine kinase inhibitors and adriamycin through a mechanism unrelated to p21 and dependent on p53.
Nuria Ferrandiz, Jorge Martin-Perez, Rosa Blanco, Derya Donertas, Axel Weber, Martin Eilers, Paolo Dotto, M Dolores Delgado, Javier Leon. DNA Repair (Amst) 2009
16
100

Amphiregulin promotes BAX inhibition and resistance to gefitinib in non-small-cell lung cancers.
Benoît Busser, Lucie Sancey, Véronique Josserand, Carole Niang, Marie C Favrot, Jean-Luc Coll, Amandine Hurbin. Mol Ther 2010
47
100

Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy.
Charles Pottier, Margaux Fresnais, Marie Gilon, Guy Jérusalem, Rémi Longuespée, Nor Eddine Sounni. Cancers (Basel) 2020
122
100

Trimmomatic: a flexible trimmer for Illumina sequence data.
Anthony M Bolger, Marc Lohse, Bjoern Usadel. Bioinformatics 2014
100

Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening.
Minsuh Kim, Hyemin Mun, Chang Oak Sung, Eun Jeong Cho, Hye-Joon Jeon, Sung-Min Chun, Da Jung Jung, Tae Hoon Shin, Gi Seok Jeong, Dong Kwan Kim,[...]. Nat Commun 2019
191
100

The intestinotrophic peptide, glp-2, counteracts intestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, gefitinib.
Kristine Juul Hare, Bolette Hartmann, Hannelouise Kissow, Jens Juul Holst, Steen Seier Poulsen. Clin Cancer Res 2007
31
100

Ultra high content image analysis and phenotype profiling of 3D cultured micro-tissues.
Zi Di, Maarten J D Klop, Vasiliki-Maria Rogkoti, Sylvia E Le Dévédec, Bob van de Water, Fons J Verbeek, Leo S Price, John H N Meerman. PLoS One 2014
28
100


Human Enteroids/Colonoids and Intestinal Organoids Functionally Recapitulate Normal Intestinal Physiology and Pathophysiology.
Nicholas C Zachos, Olga Kovbasnjuk, Jennifer Foulke-Abel, Julie In, Sarah E Blutt, Hugo R de Jonge, Mary K Estes, Mark Donowitz. J Biol Chem 2016
154
100


Three-dimensional cell culture systems as an in vitro platform for cancer and stem cell modeling.
Nipha Chaicharoenaudomrung, Phongsakorn Kunhorm, Parinya Noisa. World J Stem Cells 2019
116
100

Gefitinib, a selective EGFR tyrosine kinase inhibitor, induces apoptosis through activation of Bax in human gallbladder adenocarcinoma cells.
Hiroshi Ariyama, Baoli Qin, Eishi Baba, Risa Tanaka, Kenji Mitsugi, Mine Harada, Shuji Nakano. J Cell Biochem 2006
56
100

The ConsensusPathDB interaction database: 2013 update.
Atanas Kamburov, Ulrich Stelzl, Hans Lehrach, Ralf Herwig. Nucleic Acids Res 2013
523
100

Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol.
Helen C Swaisland, Malcolm Ranson, Robert P Smith, Joanna Leadbetter, Alison Laight, David McKillop, Martin J Wild. Clin Pharmacokinet 2005
107
100

FOXO transcription factors.
Matthew E Carter, Anne Brunet. Curr Biol 2007
152
100

Physiologically Based Pharmacokinetic Modeling to Evaluate the Systemic Exposure of Gefitinib in CYP2D6 Ultrarapid Metabolizers and Extensive Metabolizers.
Yingxue Chen, Diansong Zhou, Weifeng Tang, Wangda Zhou, Nidal Al-Huniti, Eric Masson. J Clin Pharmacol 2018
9
100


The Reactome Pathway Knowledgebase.
Antonio Fabregat, Steven Jupe, Lisa Matthews, Konstantinos Sidiropoulos, Marc Gillespie, Phani Garapati, Robin Haw, Bijay Jassal, Florian Korninger, Bruce May,[...]. Nucleic Acids Res 2018
100

WikiPathways: connecting communities.
Marvin Martens, Ammar Ammar, Anders Riutta, Andra Waagmeester, Denise N Slenter, Kristina Hanspers, Ryan A Miller, Daniela Digles, Elisson N Lopes, Friederike Ehrhart,[...]. Nucleic Acids Res 2021
129
100


Human organoids: model systems for human biology and medicine.
Jihoon Kim, Bon-Kyoung Koo, Juergen A Knoblich. Nat Rev Mol Cell Biol 2020
381
100

Gefitinib.
Justyna Rawluk, Cornelius F Waller. Recent Results Cancer Res 2018
35
100

A Human iPSC-derived 3D platform using primary brain cancer cells to study drug development and personalized medicine.
Simon Plummer, Stephanie Wallace, Graeme Ball, Roslyn Lloyd, Paula Schiapparelli, Alfredo Quiñones-Hinojosa, Thomas Hartung, David Pamies. Sci Rep 2019
38
100

Side effects of therapy: case 1. Nephrotic syndrome associated with gefitinib therapy.
Ryuichiro Kumasaka, Norio Nakamura, Kenichi Shirato, Hiroshi Osawa, Shingo Takanashi, Yukihiro Hasegawa, Hideaki Yamabe, Masayuki Nakamura, Michiko Tamura, Ken Okumura. J Clin Oncol 2004
34
100

Establishment of Gastrointestinal Epithelial Organoids.
Maxime M Mahe, Eitaro Aihara, Michael A Schumacher, Yana Zavros, Marshall H Montrose, Michael A Helmrath, Toshiro Sato, Noah F Shroyer. Curr Protoc Mouse Biol 2013
176
100

High cholesterol in lipid rafts reduces the sensitivity to EGFR-TKI therapy in non-small cell lung cancer.
Qiufang Chen, Zhenzhen Pan, Min Zhao, Qin Wang, Chen Qiao, Liyun Miao, Xuansheng Ding. J Cell Physiol 2018
26
100

A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer.
A Goncalves, M Fabbro, C Lhommé, L Gladieff, J-M Extra, A Floquet, L Chaigneau, A Tisseron Carrasco, P Viens. Gynecol Oncol 2008
94
100

Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche.
Toshiro Sato, Robert G Vries, Hugo J Snippert, Marc van de Wetering, Nick Barker, Daniel E Stange, Johan H van Es, Arie Abo, Pekka Kujala, Peter J Peters,[...]. Nature 2009
100

Functional characterization of wild-type and 24 CYP2D6 allelic variants on gefitinib metabolism in vitro.
Ping Fang, Xiang Zheng, Jiayang He, Honglei Ge, Pengfei Tang, Jianping Cai, Guoxin Hu. Drug Des Devel Ther 2017
9
100

Organoids as an in vitro model of human development and disease.
Aliya Fatehullah, Si Hui Tan, Nick Barker. Nat Cell Biol 2016
690
100

Cytochrome P450-mediated metabolism in the human gut wall.
Kirstin Thelen, Jennifer B Dressman. J Pharm Pharmacol 2009
161
100

Quantitative Systems Toxicology Modeling To Address Key Safety Questions in Drug Development: A Focus of the TransQST Consortium.
Sofia Ferreira, Ciarán Fisher, Laura I Furlong, Loic Laplanche, Brian Kevin Park, Carmen Pin, Julio Saez-Rodriguez, Panuwat Trairatphisan. Chem Res Toxicol 2020
6
100

AURKA upregulation plays a role in fibroblast-reduced gefitinib sensitivity in the NSCLC cell line HCC827.
Jia Chen, Huiqi Lu, Wang Zhou, Huabin Yin, Lishuang Zhu, Chang Liu, Pengfei Zhang, Huimin Hu, Yili Yang, Huanxing Han. Oncol Rep 2015
13
100


Lung cancer cells survive epidermal growth factor receptor tyrosine kinase inhibitor exposure through upregulation of cholesterol synthesis.
Mark C Howell, Ryan Green, Roukiah Khalil, Elspeth Foran, Waise Quarni, Rajesh Nair, Stanley Stevens, Aleksandr Grinchuk, Andrew Hanna, Shyam Mohapatra,[...]. FASEB Bioadv 2019
12
100


Regional Differences in Human Intestinal Drug Metabolism.
Raditya Iswandana, Marina I Irianti, Dorenda Oosterhuis, Hendrik S Hofker, Marjolijn T Merema, Marina H de Jager, Henricus A M Mutsaers, Peter Olinga. Drug Metab Dispos 2018
6
100

Establishment of 2D Cell Cultures Derived From 3D MCF-7 Spheroids Displaying a Doxorubicin Resistant Profile.
Ana S Nunes, Elisabete C Costa, Andreia S Barros, Duarte de Melo-Diogo, Ilídio J Correia. Biotechnol J 2019
14
100

Cholesterol Biosynthesis: A Mechanistic Overview.
Nuno M F S A Cerqueira, Eduardo F Oliveira, Diana S Gesto, Diogo Santos-Martins, Cátia Moreira, Hari N Moorthy, Maria J Ramos, P A Fernandes. Biochemistry 2016
105
100

Side effects related to cancer treatment: CASE 1. Hepatitis following treatment with gefitinib.
Cheryl Ho, Jennifer Davis, Frank Anderson, Gwyn Bebb, Nevin Murray. J Clin Oncol 2005
32
100

New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids.
Daniela Rodrigues, Terezinha de Souza, Luke Coyle, Matteo Di Piazza, Bram Herpers, Sofia Ferreira, Mian Zhang, Johanna Vappiani, Daniel C Sévin, Attila Gabor,[...]. Arch Toxicol 2021
3
100


Effects of polymorphisms in CYP2D6 and ABC transporters and side effects induced by gefitinib on the pharmacokinetics of the gefitinib metabolite, O-desmethyl gefitinib.
Hiroyuki Kobayashi, Kazuhiro Sato, Takenori Niioka, Masahide Takeda, Yuji Okuda, Mariko Asano, Hiroshi Ito, Masatomo Miura. Med Oncol 2016
19
100

Gefitinib-resistance is related to BIM expression in non-small cell lung cancer cell lines.
Heyan Li, Songwen Zhou, Xuefei Li, Daoyuan Wang, Yongsheng Wang, Caicun Zhou, Gerald Schmid-Bindert. Cancer Biother Radiopharm 2013
23
100

The Simcyp population-based ADME simulator.
Masoud Jamei, Steve Marciniak, Kairui Feng, Adrian Barnett, Geoffrey Tucker, Amin Rostami-Hodjegan. Expert Opin Drug Metab Toxicol 2009
339
100

Pharmacokinetics of Gefitinib: Roles of Drug Metabolizing Enzymes and Transporters.
Can Zhao, Shu-Yan Han, Ping-Ping Li. Curr Drug Deliv 2017
17
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.